We evaluated the effects of pretreatment with atorvastatin on postprocedural release of markers of myocardial damage in patients with stable angina undergoing percutaneous coronary intervention. Results showed that pretreatment with atorvastatin favorably affected the cardiac markers creatine kinase-MB, troponin I, and myoglobin, which significantly reduced myocardial injury.
Atorvastatin treatment during coronary intervention
Patti G;
2005-01-01
Abstract
We evaluated the effects of pretreatment with atorvastatin on postprocedural release of markers of myocardial damage in patients with stable angina undergoing percutaneous coronary intervention. Results showed that pretreatment with atorvastatin favorably affected the cardiac markers creatine kinase-MB, troponin I, and myoglobin, which significantly reduced myocardial injury.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
